drugset / Trial / NCT07635043

Efficacy of Topical Tapinarof Versus Betamethasone in the Treatment of Plaque Psoriasis

NCT07635043

Phase 4 Not yet recruiting 120 enrolled Pakistan Institute of Medical Sciences
Non-randomizedParallel-groupOpen-labelTreatment

Summary

To assess the effectiveness of topical tapinarof to topical betamethasone in patients with mild to moderate plaque psoriasis presenting to tertiary care hospital in Islamabad

Timeline

Start
2026-08-01
Primary completion
2026-10-31
Completion
2026-11-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Tapinarof Other / unclassified 1 % Topical
Comparator betamethasone dipropionate Small molecule 0.05 % Topical

Indications